The V1, V2, and V3 regions of the human immunodeficiency virus type 1 envelope differentially affect the viral phenotype in an isolate-dependent manner

被引:96
作者
Saunders, CJ
McCaffrey, RA
Zharkikh, I
Kraft, Z
Malenbaum, SE
Burke, B
Cheng-Mayer, C
Stamatatos, L
机构
[1] Seattle Biomed Res Inst, Seattle, WA 98109 USA
[2] Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA
[3] Aaron Diamond AIDS Res Ctr, New York, NY USA
关键词
D O I
10.1128/JVI.79.14.9069-9080.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
It is well documented that removal of the V1V2 region or of the V2 loop alone from the envelope glycoprotein of human immunodeficiency virus type 1 (HIV-1) or simian immunodeficiency virus (SIV) increases the susceptibility of these viruses to neutralization by antibodies. The specific role of the V1 loop in defining the neutralization susceptibility of HIV is, however, not well documented. Our current studies indicate that although the V1V2 region is a global modulator of the HIV-1 neutralization susceptibility, the individual roles the V1 and V2 loops have in defining the neutralization susceptibility profile of HIV-1 differ and in some cases are opposite. While deletion of the V2 loop renders the virus more susceptible to neutralization by antibodies that recognize diverse epitopes, in particular certain ones located in the CD4 binding site and the V3 loop, deletion of the V1 loop renders the virus refractory to neutralization, especially by antibodies that recognize CD4-induced epitopes and certain CD4-site binding antibodies. Our current studies also indicate that the relative involvement of the V2 loop of the HIV-1 envelope during virus-cell entry appears to be envelope background dependent. As a result, although deletion of the V2 loop from the clade B, R5-tropic SF162 HIV-1 virus resulted in a virus that was replication competent, the same modification introduced on the background of two other R5-tropic isolates, SF128A (clade B) or SF170 (clade A), abrogated the ability of these envelopes to mediate virus-cell entry.
引用
收藏
页码:9069 / 9080
页数:12
相关论文
共 65 条
[1]   Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies [J].
Binley, JA ;
Wrin, T ;
Korber, B ;
Zwick, MB ;
Wang, M ;
Chappey, C ;
Stiegler, G ;
Kunert, R ;
Zolla-Pazner, S ;
Katinger, H ;
Petropoulos, CJ ;
Burton, DR .
JOURNAL OF VIROLOGY, 2004, 78 (23) :13232-13252
[2]   A SINGLE AMINO-ACID SUBSTITUTION IN THE V1 LOOP OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 ALTERS CELLULAR TROPISM [J].
BOYD, MT ;
SIMPSON, GR ;
CANN, AJ ;
JOHNSON, MA ;
WEISS, RA .
JOURNAL OF VIROLOGY, 1993, 67 (06) :3649-3652
[3]   Priming B cell-mediated anti-HIV envelope responses by vaccination allows for the long-term control of infection in macaques exposed to a R5-tropic SHIV [J].
Buckner, C ;
Gines, LG ;
Saunders, CJ ;
Vojtech, L ;
Srivastava, I ;
Gettie, A ;
Bohm, R ;
Blanchard, J ;
Barnett, SW ;
Safrit, JT ;
Stamatatos, L .
VIROLOGY, 2004, 320 (01) :167-180
[4]   EFFICIENT NEUTRALIZATION OF PRIMARY ISOLATES OF HIV-1 BY A RECOMBINANT HUMAN MONOCLONAL-ANTIBODY [J].
BURTON, DR ;
PYATI, J ;
KODURI, R ;
SHARP, SJ ;
THORNTON, GB ;
PARREN, PWHI ;
SAWYER, LSW ;
HENDRY, RM ;
DUNLOP, N ;
NARA, PL ;
LAMACCHIA, M ;
GARRATTY, E ;
STIEHM, ER ;
BRYSON, YJ ;
CAO, YZ ;
MOORE, JP ;
HO, DD ;
BARBAS, CF .
SCIENCE, 1994, 266 (5187) :1024-1027
[5]   Antibody domain exchange is an immunological solution to carbohydrate cluster recognition [J].
Calarese, DA ;
Scanlan, CN ;
Zwick, MB ;
Deechongkit, S ;
Mimura, Y ;
Kunert, R ;
Zhu, P ;
Wormald, MR ;
Stanfield, RL ;
Roux, KH ;
Kelly, JW ;
Rudd, PM ;
Dwek, RA ;
Katinger, H ;
Burton, DR ;
Wilson, IA .
SCIENCE, 2003, 300 (5628) :2065-2071
[6]   Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein [J].
Cao, J ;
Sullivan, N ;
Desjardin, E ;
Parolin, C ;
Robinson, J ;
Wyatt, R ;
Sodroski, J .
JOURNAL OF VIROLOGY, 1997, 71 (12) :9808-9812
[7]   DESIGNING CD4 IMMUNOADHESINS FOR AIDS THERAPY [J].
CAPON, DJ ;
CHAMOW, SM ;
MORDENTI, J ;
MARSTERS, SA ;
GREGORY, T ;
MITSUYA, H ;
BYRN, RA ;
LUCAS, C ;
WURM, FM ;
GROOPMAN, JE ;
BRODER, S ;
SMITH, DH .
NATURE, 1989, 337 (6207) :525-531
[8]   Selection for neutralization resistance of the simian human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation [J].
Cheng-Mayer, C ;
Brown, A ;
Harouse, J ;
Luciw, PA ;
Mayer, AJ .
JOURNAL OF VIROLOGY, 1999, 73 (07) :5294-5300
[9]   VIRAL DETERMINANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 T-CELL OR MACROPHAGE TROPISM, CYTOPATHOGENICITY, AND CD4 ANTIGEN MODULATION [J].
CHENGMAYER, C ;
QUIROGA, M ;
TUNG, JW ;
DINA, D ;
LEVY, JA .
JOURNAL OF VIROLOGY, 1990, 64 (09) :4390-4398
[10]   The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection [J].
Cocchi, F ;
DeVico, AL ;
GarzinoDemo, A ;
Cara, A ;
Gallo, RC ;
Lusso, P .
NATURE MEDICINE, 1996, 2 (11) :1244-1247